Bank of New York Mellon’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.4M | Buy |
1,625,379
+15,081
| +0.9% | +$345K | 0.01% | 1314 |
|
|
2026
Q1 | $35.5M | Sell |
1,610,298
-53,992
| -3% | -$940K | 0.01% | 1210 |
|
|
2025
Q4 | $19.6M | Buy |
1,664,290
+570,543
| +52% | +$7.33M | ﹤0.01% | 1556 |
|
|
2025
Q3 | $17.3M | Buy |
1,093,747
+39,127
| +4% | +$568K | ﹤0.01% | 1621 |
|
|
2025
Q2 | $12.1M | Buy |
1,054,620
+85,529
| +9% | +$964K | ﹤0.01% | 1795 |
|
|
2025
Q1 | $13.1M | Sell |
969,091
-80,894
| -8% | -$1.34M | ﹤0.01% | 1725 |
|
|
2024
Q4 | $17.7M | Sell |
1,049,985
-438,931
| -29% | -$8.54M | ﹤0.01% | 1639 |
|
|
2024
Q3 | $30.3M | Sell |
1,488,916
-117,537
| -7% | -$2.4M | 0.01% | 1334 |
|
|
2024
Q2 | $36.3M | Buy |
1,606,453
+22,209
| +1% | +$582K | 0.01% | 1218 |
|
|
2024
Q1 | $41.6M | Sell |
1,584,244
-4,202,981
| -73% | -$120M | 0.01% | 1145 |
|
|
2023
Q4 | $183M | Sell |
5,787,225
-408,838
| -7% | -$11.1M | 0.04% | 398 |
|
|
2023
Q3 | $174M | Buy |
6,196,063
+612,071
| +11% | +$21M | 0.04% | 397 |
|
|
2023
Q2 | $206M | Buy |
5,583,992
+3,608,478
| +183% | +$110M | 0.04% | 362 |
|
|
2023
Q1 | $59.1M | Sell |
1,975,514
-140,118
| -7% | -$4.62M | 0.01% | 899 |
|
|
2022
Q4 | $64.8M | Sell |
2,115,632
-101,349
| -5% | -$3.04M | 0.01% | 831 |
|
|
2022
Q3 | $54.6M | Sell |
2,216,981
-36,996
| -2% | -$1.22M | 0.01% | 907 |
|
|
2022
Q2 | $72.2M | Buy |
2,253,977
+74,976
| +3% | +$2.76M | 0.02% | 761 |
|
|
2022
Q1 | $68.6M | Sell |
2,179,001
-46,227
| -2% | -$1.45M | 0.01% | 880 |
|
|
2021
Q4 | $74.7M | Buy |
2,225,228
+39,606
| +2% | +$1.23M | 0.01% | 877 |
|
|
2021
Q3 | $63.5M | Sell |
2,185,622
-29,950
| -1% | -$970K | 0.01% | 980 |
|
|
2021
Q2 | $77.1M | Buy |
2,215,572
+35,804
| +2% | +$1.19M | 0.01% | 856 |
|
|
2021
Q1 | $60.8M | Sell |
2,179,768
-71,154
| -3% | -$1.89M | 0.01% | 980 |
|
|
2020
Q4 | $55.8M | Sell |
2,250,922
-847,641
| -27% | -$20.2M | 0.01% | 976 |
|
|
2020
Q3 | $64.8M | Sell |
3,098,563
-26,471
| -0.8% | -$511K | 0.02% | 764 |
|
|
2020
Q2 | $48M | Buy |
3,125,034
+95,563
| +3% | +$1.21M | 0.01% | 903 |
|
|
2020
Q1 | $26.9M | Sell |
3,029,471
-165,327
| -5% | -$2.38M | 0.01% | 1106 |
|
|
2019
Q4 | $57.8M | Buy |
3,194,798
+500,177
| +19% | +$8.31M | 0.01% | 889 |
|
|
2019
Q3 | $40.3M | Sell |
2,694,621
-84,261
| -3% | -$1.37M | 0.01% | 1078 |
|
|
2019
Q2 | $66.7M | Sell |
2,778,882
-105,662
| -4% | -$3.11M | 0.02% | 796 |
|
|
2019
Q1 | $107M | Sell |
2,884,544
-261,602
| -8% | -$9.52M | 0.03% | 551 |
|
|
2018
Q4 | $88.8M | Buy |
3,146,146
+860,666
| +38% | +$27.2M | 0.03% | 569 |
|
|
2018
Q3 | $90.1M | Buy |
2,285,480
+136,801
| +6% | +$5.99M | 0.02% | 667 |
|
|
2018
Q2 | $95.3M | Sell |
2,148,679
-285,591
| -12% | -$14.2M | 0.03% | 614 |
|
|
2018
Q1 | $119M | Sell |
2,434,270
-132,148
| -5% | -$6.61M | 0.03% | 507 |
|
|
2017
Q4 | $128M | Buy |
2,566,418
+194,509
| +8% | +$10.2M | 0.03% | 507 |
|
|
2017
Q3 | $120M | Buy |
2,371,909
+173,523
| +8% | +$8.19M | 0.03% | 519 |
|
|
2017
Q2 | $83.4M | Sell |
2,198,386
-85,497
| -4% | -$3.37M | 0.02% | 670 |
|
|
2017
Q1 | $87.9M | Sell |
2,283,883
-154,187
| -6% | -$4.64M | 0.02% | 640 |
|
|
2016
Q4 | $53.9M | Sell |
2,438,070
-267,731
| -10% | -$5.5M | 0.02% | 897 |
|
|
2016
Q3 | $43.3M | Buy |
2,705,801
+163,893
| +6% | +$1.87M | 0.01% | 965 |
|
|
2016
Q2 | $20.9M | Sell |
2,541,908
-30,683
| -1% | -$273K | 0.01% | 1383 |
|
|
2016
Q1 | $18M | Buy |
2,572,591
+226,254
| +10% | +$1.14M | 0.01% | 1478 |
|
|
2015
Q4 | $12.6M | Sell |
2,346,337
-85,097
| -3% | -$544K | ﹤0.01% | 1712 |
|
|
2015
Q3 | $15.7M | Buy |
+2,431,434
| New | +$25.5M | ﹤0.01% | 1585 |
|
Other funds holding CC
PCM
PMG
FNFDCM
AFAS
OWIM
Bank of New York Mellon's CC Position: Q2 2026 in Review
Bank of New York Mellon increased its Chemours (CC) stake by 0.94% in Q2 2026, buying an estimated $345K and bringing the position to 1,625,379 shares worth $33.4M. The position accounts for 0.01% of the portfolio, ranked #1314.
Bank of New York Mellon first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $206M in Q2 2023. 252 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Bank of New York Mellon held 1,625,379 shares of Chemours worth $33.4M as of Q2 2026.
- Bank of New York Mellon bought 15,081 Chemours shares in Q2 2026, an estimated $345K.
- Chemours made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1314 holding.
- Bank of New York Mellon first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
- Bank of New York Mellon's Chemours position peaked at $206M in Q2 2023.
- 252 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.